EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GSK-J4 Suppresses Tumorigenesis by Targeting the PERK-c-Myc Pathway Through Endoplasmic Reticulum Stress Activation in Tuberous Sclerosis Complex

Xin Lei, Tao Lang, Ping Li iD, Changxin Wu iD

International Journal of Molecular Sciences · 27.03.2026 · 27 (7) · 3067

DOI: 10.3390/ijms27073067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.03.2026. Verfasst von Xin Lei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Provincial Key Laboratory of Medical Molecular Cell Biology, Institutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, Endoplasmic Reticulum Stress, Tuberous Sclerosis, eIF-2 Kinase. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The limited and inconsistent efficacy of existing therapies for tuberous sclerosis complex (TSC) has driven the exploration of novel strategies, including epigenetic regulation. GSK-J4, an inducer of global H3K27me3 accumulation, shows broad anti-tumor activity. However, its therapeutic potential in TSC remains unclear. In the study, we reported that GSK-J4 inhibited cell cycle progression and induced apoptosis in primary Tsc1+/− and Tsc2+/− MEFs. Mechanistically, Tsc1 or Tsc2 deletion reduced global H3K27me3, correlating with increased viability, accelerated cell cycle, and suppressed apoptosis-phenotypes reversed by GSK-J4. Moreover, GSK-J4 triggered endoplasmic reticulum stress (ERS) by activating the PERK-ATF4-CHOP axis, which concurrently downregulated the proto-oncogene c-Myc, outlining a GSK-J4→p-PERK→c-Myc inhibitory pathway. Notably, GSK-J4 synergized with rapamycin to enhance cell cycle arrest and apoptosis. In vivo, this combination alleviated renal impairment in Tsc1- or Tsc2-deficient models, suggesting a promising therapeutic strategy for TSC patients with suboptimal response to mammalian target of rapamycin complex 1 (mTORC1) inhibitors. Our study elucidates a specific ERS-dependent anti-tumor mechanism of GSK-J4 in Tsc-deficient contexts and demonstrates the synergistic efficacy of combining epigenetic and mTORC1 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mycEndoplasmic Reticulum StressTuberous SclerosiseIF-2 KinaseCarcinogenesisAnimalsHumansTuberous Sclerosis Complex 2 ProteinTuberous Sclerosis Complex 1 ProteinApoptosisSignal TransductionMiceProto-Oncogene Mas

Stichwörter der Autor:innen

GSK-J4apoptosisendoplasmic reticulum stresshistone modificationrapamycintuberous sclerosis complex

Substanzen

Proto-Oncogene Proteins c-mycTuberous Sclerosis Complex 2 ProteinTuberous Sclerosis Complex 1 ProteineIF-2 KinaseProto-Oncogene MasTsc2 protein, mouseMAS1 protein, humanTsc1 protein, mouse

Autor:innen und Institutionen

  • Shanxi Provincial Key Laboratory of Medical Molecular Cell Biology, Institutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China.
  • Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education of China, Shanxi University, Taiyuan 030006, China.

ORCID-Profile: Ping Li, Changxin Wu

Förderung

  • the National Natural Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Lei, X., Lang, T., Li, P., & Wu, C. (2026). GSK-J4 Suppresses Tumorigenesis by Targeting the PERK-c-Myc Pathway Through Endoplasmic Reticulum Stress Activation in Tuberous Sclerosis Complex. International Journal of Molecular Sciences, 27(7), 3067. https://doi.org/10.3390/ijms27073067

Vancouver

Lei X, Lang T, Li P, Wu C. GSK-J4 Suppresses Tumorigenesis by Targeting the PERK-c-Myc Pathway Through Endoplasmic Reticulum Stress Activation in Tuberous Sclerosis Complex. International Journal of Molecular Sciences. 2026;27(7):3067. doi:10.3390/ijms27073067

BibTeX
@article{Lei2026,
  author = {Lei, Xin and Lang, Tao and Li, Ping and Wu, Changxin},
  title = {GSK-J4 Suppresses Tumorigenesis by Targeting the PERK-c-Myc Pathway Through Endoplasmic Reticulum Stress Activation in Tuberous Sclerosis Complex},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3067},
  doi = {10.3390/ijms27073067}
}
Kostenlos starten →